FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Gland Pharma IPO and Mazagon Dock IPO.
Gland Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mazagon Dock IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Gland Pharma IPO | Mazagon Dock IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Citigroup Global Markets India Private Limited Haitong Securities India Private Limited Kotak Mahindra Capital Company Limited Nomura Financial Advisory And Securities (India) Pvt Ltd |
Axis Capital Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Edelweiss Financial Services Ltd Jm Financial Limited Yes Securities (India) Limited |
Registrar | Link Intime India Private Ltd | Alankit Assignments Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Gland Pharma IPO is up to ₹6,479.55 Cr whereas the issue size of the Mazagon Dock IPO is up to ₹443.69 Cr. The final issue price of Gland Pharma IPO is ₹1,500.00 per share and of Mazagon Dock IPO is ₹145.00 per share.
Gland Pharma IPO | Mazagon Dock IPO | |
---|---|---|
Face Value | ₹1 per share | ₹10 per share |
Issue Price (Lower) | ₹1,490.00 per share | ₹135.00 per share |
Issue Price (Upper) | ₹1,500.00 per share | ₹145.00 per share |
Issue Price (Final) | ₹1,500.00 per share | ₹145.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 10 shares | 103 shares |
Fresh Issue Size | 83,33,333 shares | |
Fresh Issue Size (Amount) | up to ₹1,250.00 Cr | |
OFS Issue Size | 3,48,63,635 shares | 3,05,99,017 shares |
OFS Issue Size (Amount) | up to ₹5,229.55 Cr | up to ₹443.69 Cr |
Issue Size Total | 4,31,96,968 shares | 3,05,99,017 shares |
Issue Size Total (Amount) | up to ₹6,479.55 Cr | up to ₹443.69 Cr |
Gland Pharma IPO opens on Nov 09, 2020, while Mazagon Dock IPO opens on Sep 29, 2020. The closing date of Gland Pharma IPO and Mazagon Dock IPO is Nov 11, 2020, and Oct 01, 2020, respectively.
Gland Pharma IPO | Mazagon Dock IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Nov 09, 2020 | Sep 29, 2020 |
Issue Close | Nov 11, 2020 | Oct 01, 2020 |
Basis Of Allotment (Tentative) | Nov 17, 2020 | Oct 07, 2020 |
Initiation of Refunds (Tentative) | Nov 18, 2020 | Oct 08, 2020 |
Credit of Share (Tentative) | Nov 19, 2020 | Oct 09, 2020 |
Listing date (Tentative) | Nov 20, 2020 | Oct 12, 2020 |
Anchor Lockin End date 1 | Dec 17, 2020 | Nov 06, 2020 |
Anchor Lockin End date 2 | Feb 15, 2021 | Jan 05, 2021 |
Gland Pharma IPO P/E ratio is , as compared to Mazagon Dock IPO P/E ratio of .
Gland Pharma IPO | Mazagon Dock IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 74% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 58% | 85% | ||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Gland Pharma IPO retail investors (RII) are offered 1,51,18,939 shares while in Mazagon Dock IPO retail investors are offered 1,51,18,939 shares. Qualified institutional buyers (QIB) are offered 86,39,394 shares in Gland Pharma IPO and 1,51,26,750 shares in Mazagon Dock IPO.
Gland Pharma IPO | Mazagon Dock IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 86,39,394 shares | 1,51,26,750 shares |
NII | 64,79,546 shares | 45,38,025 shares |
RII | 1,51,18,939 shares | 1,05,88,725 shares |
Employee | 0 shares | 3,45,517 shares |
Others | ||
Total | 3,02,37,879 shares | 3,05,99,017 shares |
Gland Pharma IPO subscribed 2.06x in total, whereas Mazagon Dock IPO subscribed 157.41x.
Gland Pharma IPO | Mazagon Dock IPO | |
---|---|---|
QIB (times) | 6.40x | 89.71x |
NII (times) | 0.51x | 678.88x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 0.24x | 35.63x |
Employee (times) | 3.88x | |
Other (times) | ||
Total (times) | 2.06x | 157.41x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|